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Background. *e correlation between epidurography contrast patterns and the clinical outcomes of percutaneous epidural
neuroplasty (PEN) remains unclear. Objective. To analyze the correlation between postadhesiolysis epidurography contrast
patterns and the clinical outcomes of patients who undergo lumbar PEN. Design. *is study is a retrospective analysis of 78
consecutive patients who underwent lumbar PEN between April 2012 and March 2013. Setting. *e analysis was done in the
university hospital center. Method. *e clinical outcomes of all patients were assessed before and 1, 3, 6, and 12 months after
undergoing lumbar PEN. Speciﬁcally, the intensity of back and leg pain, quality of life, and procedural outcomes were evaluated
using a visual analog scale (VAS), the Oswestry Disability Index (ODI), and the 12-Item Short-Form Health Survey (SF-12).
Results. *e VAS scores for back and leg pain, ODI score, and SF-12 score exhibited a signiﬁcant improvement during the follow-
up period (P< 0.01 versus preprocedural scores). At most follow-up time points, patients exhibiting extraforaminal contrast
distribution (n � 22) on postadhesiolysis epidurograms exhibited a similar improvement in VAS scores and a signiﬁcantly better
improvement in ODI and SF-12 scores compared with patients exhibiting intracanal contrast distribution (n � 56). Conclusion.
Extraforaminal contrast distribution during lumbar PEN may be associated with better functional outcomes.
1. Introduction
Chronic low back pain is a common health problem with
widespread socioeconomical reverberations which is expe-
rienced by most individuals at some point in their lives [1–3].
Several studies on low back pain have been conducted, and
many treatments have been applied, with most physicians
focusing on lumbar disc herniation as a leading cause for
spinal interventions [4–7]. *e demand for spinal interven-
tions is increasing because of their minimal invasiveness and
therapeutic eﬃcacy [4–7]. Percutaneous epidural neuroplasty
(PEN) is a novel, widely used technique for the lysis of mi-
croscopic adhesions surrounding nerve tissues and delivery of
therapeutic drugs directly to the target area [8–15]. However,
spinal interventions may not always be successful because of
several barriers. For example, postoperative scarring inhibits
epidural contrast spread, while foraminal stenosis blocks the
extraforaminal extension of injected drugs [16, 17]. In ad-
dition to obvious masses and canal narrowing, microscopic
adhesions, which may be a result of chronic inﬂammation,
can interrupt the spread of drugs. Although numerous studies
have described PEN procedures, only a few have reported
intraoperative ﬁndings that indicate the surgical outcomes
[11, 13, 14, 17–19]. Epidurography is always performed
during PEN procedures, but there is insuﬃcient evidence
supporting the usefulness of this procedure. Moreover, the
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correlation between epidurography contrast patterns and the
clinical outcomes of PEN has not been frequently reported
[19, 20]. Postadhesiolysis epidurography patterns are assumed
to be indicators of surgical outcomes. In addition, the
presence of poor contrast spread on postadhesiolysis epi-
durograms may be associated with the requirement for repeat
adhesiolysis procedures or a change in the target area for
achieving better contrast patterns. In the present study, we
assessed the clinical outcomes of lumbar PEN on the basis of
contrast patterns on postadhesiolysis epidurograms.
2. Methods
2.1. Patient Selection. *is retrospective analysis of medical
and radiographic records included 78 patients who un-
derwent lumbar PEN procedures between April 2012 and
March 2013 at a single university hospital. *e study protocol
was approved by the ethics committee, and informed consent
was obtained from all subjects. *e inclusion criterion was
chronic low back pain with or without leg pain due to lumbar
disc herniation and/or lumbar spinal stenosis. All patients
reported a history of discogenic or radicular symptoms re-
fractory to conservative treatments for aminimum of 6 weeks.
Diagnoses were established using magnetic resonance im-
aging (MRI) and/or computed tomography (CT) performed
before PEN. Patients with a history of spinal surgery and those
with cauda equina syndrome, bleeding diathesis, associated
somatic or psychiatric disease, vertebral fractures, pregnancy,
and tumors or other underlying systemic diseases that could
signiﬁcantly aﬀect the procedural outcomes were excluded.
All procedures were performed by one of the authors (DAS)
using the same procedural protocol.
2.2. PEN Procedure. A standard PEN procedure was used to
lyse adhesions and achieve nerve blockades in all patients, as
previously described [11, 14]. A 1-day protocol was followed.
*e patient was placed on a radiolucent table in the prone
position, and the procedure was performed under ﬂuoro-
scopic guidance. *e coccygeal and sacral regions were dis-
infected with 10% Betadine, and the surgical site was draped
in the usual aseptic manner. *e sacral hiatus was anes-
thetized with 1% xylocaine. *en, a 20-G Tuohy needle was
introduced into the epidural space below the level of S3. A
total of 3mL of the contrast agent (Omnipaque, GE
Healthcare Korea, Seoul, Republic of Korea) was instilled to
conﬁrm the epidural space and preadhesiolysis status. Both
anteroposterior and lateral ﬂuoroscopic views were obtained.
We also assessed the development of any adverse reactions.
On conﬁrmation of the target for PEN, a catheter specialized
for adhesiolysis (TUN-L-KATH; Epimed, TX, United States)
was gently inserted toward the target site. For better catheter
manipulation, the tip was bent for an approximate length of
1 cm. *e catheter was easily navigated by rotation. Once it
reached the target site, a second epidurogramwas obtained by
injecting 3mL of the contrast agent for the identiﬁcation of
ﬁlling defects or cutoﬀ signs surrounding the target area.
When the tip of the catheter touched the target site or the
contrast agent exerted pressure on the lesion, patients were
asked to report provoked symptoms. According to the sur-
gical records, they frequently reported pain similar to what
they had been suﬀering. Both mechanical and chemical
adhesiolysis were performed. *e former was achieved
through pushing, pulling, and rotating movements of the
catheter, while the latter was achieved by the injection of
a mixture comprising 0.9% normal saline (10mL) and 3000U
of hyaluronidase (H-lase; 1500U/mL; Kuhnil, South Korea).
Following adhesiolysis, a third epidurogram was obtained
using 3mL of the contrast agent. *e patterns of contrast
dispersal were examined on both anteroposterior and lateral
ﬂuoroscopic views. All epidurogram images were saved in the
Digital Imaging and Communications inMedicine format for
future analysis, and the third epidurogram was used for
analysis in our study. Finally, a mixture of 0.2% ropivacaine
(8mL; Naropin; Astrazeneca Korea, Seoul, Republic of Korea)
and 40% triamcinolone acetonide (20mg; triamcinolone;
DongKwang, Seoul, Republic of Korea) was slowly injected.
*e stored movie clips and still images were independently
reviewed twice by two authors who were blinded to the
patient data (SHP and PGC).
2.3. Epidurography Contrast Patterns. Postadhesiolysis epi-
durography contrast patterns were deﬁned and classiﬁed
into ﬁve grades according to the system proposed by Mathis
et al. [21]: grade 1, contrast spread to the medial or midline
zone of the ipsilateral or contralateral epidural space; grade 2,
contrast spread to the lateral epidural space, proximal to the
medial border of the neural foramen; grade 3, contrast spread
to the intraforaminal space, not extending to the lateral border
of the neural foramen; grade 4, contrast spread to the
intraforaminal space, extending to but not crossing the lateral
border of the neural foramen; and grade 5, contrast spread
beyond the lateral border of the neural foramen (Figure 1).
For the comparison of clinical outcomes according to the
contrast distribution pattern on epidurograms, patients with
grade 1, grade 2, and grade 3 patterns were assigned to a group
exhibiting limited intracanal spread (IC group), while patients
with grade 4 and grade 5 patterns were assigned to a group
exhibiting extended extraforaminal spread (EF group).
2.4. Follow-Up and Assessment of Surgical Outcomes. All
patients were clinically evaluated before and 1, 3, 6, and 12
months after PEN by a nurse specialized in pain manage-
ment and blinded to the treatment details. *e intensity of
leg and back pain was assessed using a subjective visual
analog scale (VAS) calibrated from 0 to 10 (0� no pain and
10� the worst pain imaginable). For functional assessments,
the Korean versions of the Oswestry Disability Index (ODI)
and 12-Item Short-Form Health Survey (SF-12) were used
[22, 23]. ODI evaluated the clinical eﬀectiveness of PEN in
terms of pain reduction and functional improvement, with
the score ranging from 0 to 50. SF-12 incorporates two
dimensions: a physical component summary (PCS) and
a mental component summary (MCS). PCS and MCS scores
are computed from the scores for 12 questions and range
from 0 to 100, with a higher score representing better
physical or mental health [19].




Figure 1: Modiﬁed classiﬁcation of epidurography contrast patterns. (a) Grade 1: contrast spread to the medial or midline zone of the
ipsilateral or contralateral epidural space, (b) grade 2: contrast spread to the lateral epidural space, proximal to the medial border of the
neural foramen, (c) grade 3: contrast spread to the intraforaminal space, not extending to the lateral border of the neural foramen, (d) grade
4: contrast spread to the intraforaminal space, extending to but not crossing the lateral border of the neural foramen, and (e) grade 5:
contrast spread beyond the lateral border of the neural foramen. Patients with grade 1, grade 2, and grade 3 patterns were assigned to a group
exhibiting limited intracanal spread (IC group), while patients with grade 4 and grade 5 patterns were assigned to a group exhibiting
extended extraforaminal spread (EF group).
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2.5. Statistical Analysis. Age, the duration of symptoms and
follow-up, and VAS, ODI, and SF-12 scores are expressed as
means± standard deviations. Student’s t-tests were used to
assess diﬀerences in VAS, ODI, and SF-12 scores at each
time point between the EF and IC groups. Chi-square tests
were used to compare clinical outcomes between the two
groups. Spearman’s rank correlation tests were used to
determine the correlation between epidurography contrast
patterns and clinical outcomes. All statistical analyses were
performed using the Statistical Package for the Social Sci-
ences software (SPSS Inc., Chicago, Illinois, USA). A P value
of <0.05 was considered statistically signiﬁcant.
3. Results
3.1. Patient Characteristics. A total of 78 patients (27 men
and 51 women) were included in this study. All patients were
clinically followed up for more than 11months.*emean age
was 58.1± 14.1 years (range, 18 to 84 years), and the average
duration of major symptoms before PENwas 7.1± 4.1months
(range, 2 to 31 months). Before PEN, the VAS score for back
pain, VAS score for leg pain, ODI score, and SF-12 score were
5.8± 2.6, 5.0± 3.1, 19.4± 7.0, and 30.0± 7.2, respectively
(Table 1).
3.2. Treatment Outcomes. *e clinical outcomes of patients
exhibited a signiﬁcant improvement during the follow-up
period. At 1, 3, 6, and 12 months after PEN, the VAS score
for back pain was 2.6± 2.3, 3.1± 2.1, 3.0± 2.0, and 3.4± 2.4,
respectively; the VAS score for leg pain was 1.9± 2.0, 2.6±
2.1, 2.6± 2.2, and 2.7± 2.6, respectively; the ODI score was
10.6± 8.0, 11.7± 7.4, 11.0± 7.3, and 11.0± 8.0, respectively;
and the SF-12 score was 41.8± 9.6, 40.5± 9.0, 41.2± 9.2, and
41.2± 10.2, respectively (P< 0.01 when compared with
preprocedural scores; Figure 2).
3.3. Postadhesiolysis Epidurography Contrast Patterns and
Clinical Outcomes. *e patients were categorized into IC
and EF groups according to the contrast patterns on
postadhesiolysis epidurograms. In the IC group (n � 56),
there were 19, 25, and 12 patients with grade 1, grade 2, and
grade 3 patterns, respectively. In the EF group (n � 22),
there were 7 and 15 patients with grade 4 and grade 5
patterns, respectively. Before PEN, the VAS score for back
pain was 5.7± 2.6 and 6.0± 2.4 (P � 0.639), the VAS score
for leg pain was 4.7± 3.1 and 6.0± 2.8 (P � 0.101), the ODI
score was 20.0± 6.9 and 17.8± 7.1 (P � 0.222), and the SF-
12 score was 29.6± 7.0 and 31.0± 7.7 (P � 0.452) in the IC
and EF groups, respectively, with no signiﬁcant diﬀerences
between groups. At most follow-up time points, the EF
group exhibited a similar improvement in VAS scores and
a signiﬁcantly better improvement in ODI and SF-12 scores
compared with the IC group (Table 2). *us, extraforaminal
contrast spread was associated with a tendency for decreased
pain and signiﬁcantly better quality of life (Figure 3;
Spearman’s rank correlation test (P< 0.05)). A represen-
tative case of a patient with radicular pain in the left leg who
exhibited signiﬁcant pain relief and functional recovery after
PEN is depicted in Figure 4.
4. Discussion
Epidurograms provide anatomical information and help in
conﬁrming accurate needle placement. Spinal interventions
can be safely performed using a ﬂuoroscope and epiduro-
grams with radiopaque dye. *e aim of the present study was
to evaluate the correlation between contrast patterns on
postadhesiolysis epidurograms and clinical outcomes in pa-
tients who underwent lumbar PEN. We observed that PEN
ameliorated the pain associated with lumbar disc herniation
and/or lumbar spinal stenosis. VAS scores for leg and back
pain, ODI scores, and SF-12 scores exhibited a signiﬁcant
improvement over the entire 12-month follow-up period.
Racz et al. [24] reported similar results in their study, where
Table 1: Baseline characteristics of patients with chronic low back
pain with or without leg pain who underwent lumbar percutaneous
epidural neuroplasty.
Variable Range
Number of patients (men :
women) 78 27 : 51
Age (years) 58.1± 14.1 18–84
Symptom duration (months) 7.1± 4.1 2–31
Follow-up duration (months) 12.7 ± 1.0 11–16
VAS score Back pain 5.8± 2.6 —Leg pain 5.0± 3.1 —
ODI score 19.4± 7.0 —
SF-12 score 30.0± 7.2 —
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Figure 2: Clinical outcomes of patients who underwent lumbar
PEN. VAS, ODI, and SF-12 scores before and 1, 3, 6, and 12months
after lumbar PEN. All postprocedural clinical scores have signif-
icantly improved compared with preprocedural scores (P< 0.001).
VAS: visual analog scale, ODI: Oswestry Disability Index, SF-12:
12-Item Short-Form Health Survey, and PEN: percutaneous epi-
dural neuroplasty.
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immediate pain relief was observed after PEN in more than
70% patients and the outcomes were maintained for 6
months. *e success rate for PEN is reported to be 50%–71%
[11, 14, 18, 25, 26]. *e present study also showed good
clinical outcomes, with the greatest improvement observed at
1 month after PEN. Moreover, the improved outcomes were
maintained without much variation for 1 year after the
procedure. *e immediate eﬀect of PEN is believed to result
from the combined eﬀects of mechanical adhesiolysis,
chemical adhesiolysis, and local lavage of inﬂammatory
Table 2: Clinical outcomes of patients with limited intracanal contrast spread (IC group) and those with extended extraforaminal contrast
spread (EC group) on postadhesiolysis epidurograms obtained during lumbar percutaneous epidural neuroplasty (PEN).
VAS score for back pain VAS score for leg pain ODI score SF-12 score
Before PEN
IC group 5.7± 2.6 4.7± 3.1 20.0± 6.9 29.6± 7.0
EF group 6.0± 2.4 6.0± 2.8 17.8± 7.1 31.0± 7.7
P value 0.639 0.101 0.222 0.452
1 month after PEN
IC group 2.9± 2.3 2.0± 2.1 12.1± 8.4 40.3± 10.2
EF group 1.9± 2.1 1.7± 1.8 6.7± 5.6 45.7± 8.5
P value 0.076 0.532 0.007 0.023
3 months after PEN
IC group 3.3± 2.2 2.6± 2.2 13.0± 7.6 39.4± 9.6
EF group 2.7± 2.1 2.6± 1.9 8.5± 5.5 43.4± 8.7
P value 0.317 0.924 0.015 0.043
6 months after PEN
IC group 3.3± 2.0 2.7± 2.3 12.6± 7.6 39.4± 9.4
EF group 2.2± 2.0 2.2± 2.1 7.1± 4.8 46.0± 6.9
P value 0.032 0.372 0.002 0.007
12 months after PEN
IC group 3.7± 2.4 2.9± 2.5 12.6± 8.2 39.3± 10.3
EF group 2.7± 2.6 2.2± 2.7 7.0± 6.0 46.1± 8.3
P value 0.087 0.274 0.005 0.007
VAS: visual analog scale; ODI: Oswestry Disability Index; SF-12: 12-Item Short-Form Health Survey.
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r = –0.244
P < 0.05
Figure 3: Correlation between epidurography contrast spread after adhesiolysis during PEN and clinical outcomes. Extraforaminal contrast
spread (grades 4 and 5) is associated with a tendency for decreased pain and signiﬁcantly better quality of life compared with intracanal
spread (grades 1, 2, and 3). PEN: percutaneous epidural neuroplasty, VAS: visual analog scale, ODI: Oswestry Disability Index, and SF-12:
12-Item Short-Form Health Survey.
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mediators, which induce desensitization, neuromodulation,
and local anesthesia [8, 27].
In the present study, we found that the clinical outcomes
of lumbar PEN were correlated with the presence of extra-
foraminal contrast spread on the ﬁnal epidurogram obtained
after adhesiolysis. Extraforaminal contrast spread is believed
to be an indicator of successful adhesiolysis. *e purpose of
PEN is to eliminate the barriers in the epidural space that
disturb drug delivery. Extraforaminal contrast spread may be
related to the creation of channels around the target site
through adhesiolysis, and it facilitates drug delivery to the
lesion site. Exposure to the ideal amount of medication can
result in better pain reduction. It can also enhance the re-







Figure 4: Representative case of a 60-year-oldman with radicular pain in the left leg who underwent lumbar PEN. (a, b)Magnetic resonance
imaging shows lumbar disc herniation and foraminal stenosis at the level of L4-5-S1 (asterisks). (c) *e ﬁrst epidurogram shows a ﬁlling
defect at the left L5-S1 foramen. *e catheter is inserted to the stenotic foramen, and mechanical adhesiolysis is attempted. (d) *e ﬁnal
postadhesiolysis epidurogram shows excellent extraforaminal contrast spread. *e patient exhibited signiﬁcant pain relief and functional
recovery after PEN. PEN: percutaneous epidural neuroplasty.
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neural congestion and decrease the associated pain. *e re-
sults of our study conﬁrmed that access to the exact position
of the lesion site is associated with a better outcome. *ese
ﬁndings suggest that mechanical adhesiolysis is meaningful
only at the lesion site. Moreover, if the exact lesion site cannot
be reached, both adhesiolysis and drug delivery will fail and
the target area will remain untreated.
In 1991, Kuslich et al. [28] demonstrated pain-sensitive
structures in the spinal canal using mechanical and electrical
stimulation. *ese structures include the annulus, nerve roots,
posterior longitudinal ligament, facet joints, tendons, liga-
ments, and fascia [29]. *ere is evidence suggesting that the
distribution of pain generators is increased in the ventral
lateral space [29, 30]. Accordingly, we expected that placement
of the catheter in the ventral epidural space would be strongly
correlated with better outcomes. However, we could not
conﬁrm a direct correlation between ventral placement of the
catheter and improved outcomes. Instead, we observed that
ventral placement of the catheter tip was correlated more with
the possibility of extraforaminal contrast spread, which
resulted in better outcomes. It is assumed that adhesiolysis,
rather than ventral catheter placement, aﬀects clinical out-
comes. Further studies with larger patient samples are nec-
essary to clarify the direct eﬀects of ventral catheter placement.
We also found that the epidurography contrast pattern showed
no signiﬁcant diﬀerences among the ﬁve grades. *erefore, we
suggest that division of the pattern into two grades may be
adequate for evaluating the surgical outcomes of PEN.
In the present study, there were no direct correlations
between cutoﬀ signs or ﬁlling defects and the clinical out-
comes of PEN. In our practice, we cannot easily resolve
cutoﬀ signs and ﬁlling defects. Cutoﬀ signs are a result of
severe spinal stenosis, while ﬁlling defects are frequently
associated with disc herniations. Currently, gross adhesions
cannot be easily lysed by soft PEN. However, regardless of
the presence of cutoﬀ signs or ﬁlling defects, better outcomes
were achieved with extraforaminal contrast spread. *ere
may be microscopic adhesions that are more relevant and
can be lysed by soft PEN. Park et al. also reported that there
was no correlation between the degree of pain relief and
epidural ﬁlling defects in patients with lumbar stenosis [31].
*is study has several limitations. *ese include the small
sample size, the unequal groups, the short follow-up duration,
and the retrospective design. Future studies should ideally
include an appropriate control group. Nevertheless, the
strength of our study is the use of clinical outcome measures,
namely, ODI and SF-12, for assessment of the quality of life in
addition to pain scores. Furthermore, the results of the study
are more in line with the prognosis because the patients
received a single treatment rather than repetitive treatments.
With the use of epidurograms, physicians can design and plan
adhesiolysis that aims at a precise target point and creates
eﬀective tunnels, which will help in predicting the prognosis.
5. Conclusions
In conclusion, the ﬁndings of our study suggest that the
contrast patterns on ﬁnal epidurograms obtained after
adhesiolysis during PEN are indicators of clinical outcomes.
Speciﬁcally, extraforaminal contrast spread during PEN is
associated with better functional outcomes.
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